12 July, 2023
Georgia, renowned for its 8,000-year-old winemaking tradition, also holds a significant place in the development of phage technology and therapy. The country boasts a rich history in this field, with early research and discoveries dating back to the early 20th century. Today, Georgia continues to be a pioneer in phage therapy, with institutions like Phage Factory BioChimPharm leading the way. BioChimPharm complated EUR 6 million modernization project at the historic phage manufacturing facility in Tbilisi, which dates back to 1934.
Located in the heart of Tbilisi, the newly modernized BioChimPharm manufacturing plant operates within the historic Bacteriophage Institute. This facility is the first in the South Caucasus to produce sterile liquid dosage forms, covering the entire production cycle, from the production of active pharmaceutical ingredients (APIs) to primary and secondary packaging of medicines. This state-of-the-art facility adheres to Good Manufacturing Practice (GMP) standards to ensure the highest quality and safety of phage-based products.
As phage therapy gains recognition globally, collaboration and knowledge-sharing between institutions like Phage Factory BioChimPharm are essential for advancing the field. The pioneering work conducted in Georgia has the potential to significantly impact the global fight against antibiotic resistance. By further expanding clinical trials and collaborations, Phage Factory BioChimPharm aims to provide effective phage-based treatments for a wide range of bacterial infections.
Phage pharmaceuticals
Bacterial infections of the upper and lower respiratory tract (inflammation of the sinuses, otitis media, tonsillitis, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleuritis)
Phagyo® has liquid form that can be taken orally and/or through local procedures, in consultation with a doctor. The dosage for adults is 20ml two-three times a day. For more detailed information, please refer to this annotation.
Phage Therapy Georgia
In conclusion, Georgia’s rich history in phage technology, combined with the groundbreaking advancements made by Phage Factory BioChimPharm, positions the country at the forefront of phage therapy. With its state-of-the-art manufacturing facility and successful clinical applications, Georgia continues to contribute to the global fight against antimicrobial resistance, offering new hope in the form of phage-based treatments.
